Overview

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals

Status:
Enrolling by invitation

Trial end date:
2021-06-30

Target enrollment:

Participant gender:

Summary

This study will investigate the security and efficacy of a daily low dose of hydroxychloroquine and Bromhexine, in preventing the development of the disease from COVID-19 in Health Care Workers at a National Institute of Health In Mexico City.

Phase:

Early Phase 1

Details

Lead Sponsor:

Instituto Nacional de Rehabilitacion

Treatments:

Bromhexine
Hydroxychloroquine